Join

Compare · BIB vs HCXY

BIB vs HCXY

Side-by-side comparison of ProShares Ultra Nasdaq Biotechnology (BIB) and Hercules Capital, Inc. (HCXY): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both BIB and HCXY operate in n/a (n/a), so they compete in similar markets.
  • HCXY carries a market cap of $4.49B.
  • Over the past year, BIB is up 86.6% and HCXY is up 0.6% - BIB leads by 86.1 points.
  • HCXY has hit the wire 3 times in the past 4 weeks while BIB has been quiet.
PerformanceBIB+86.63%HCXY+0.56%
2025-07-28+0.00%2026-07-24
MetricBIBHCXY
Company
ProShares Ultra Nasdaq Biotechnology
Hercules Capital, Inc.
Price
$98.52-0.08%
$25.01+0.16%
Market cap
-
$4.49B
1M return
+6.63%
+1.09%
1Y return
+86.63%
+0.56%
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NYSE
IPO
n/a
2018
News (4w)
0
3
Recent ratings
0
0
BIB

ProShares Ultra Nasdaq Biotechnology

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Latest BIB

Latest HCXY